Prof. Dr. SADBERK LALE TOKGÖZOĞLU

Yayın Ağı

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Can apoA-I infusion decrease cardiovascular events?

Tokgozoglu L., Pirillo A., Catapano A. L.

EUROPEAN HEART JOURNAL , 2024 (SCI-Expanded)

DCRM 2.0: Multispecialty practice recommendations for the management of diabetes, cardiorenal, and metabolic diseases

Handelsman Y., Anderson J. E., Bakris G. L., Ballantyne C. M., Bhatt D. L., Bloomgarden Z. T., et al.

METABOLISM-CLINICAL AND EXPERIMENTAL , 2024 (SCI-Expanded)

Addressing residual risk beyond statin therapy: New targets in the management of dyslipidaemias-A report from the European Society of Cardiology Cardiovascular Round Table

Mach F., Visseren F. L. J., Cater N. B., Salhi N., Soronen J., Ray K. K., et al.

JOURNAL OF CLINICAL LIPIDOLOGY , cilt.18, sa.5, 2024 (SCI-Expanded)

ORION-8: one step closer to understanding the safety and efficacy of inclisiran

Tokgozoglu L., Norata G. D.

CARDIOVASCULAR RESEARCH , 2024 (SCI-Expanded)

TURK-HEART: A STUDY DESIGNED TO DETERMINE STRATEGIES FOR ACHIEVING RECOMMENDED DYSLIPIDEMIA TREATMENT GOALS IN VERY HIGH CVD RISK PATIENTS IN TURKEY

Ozdogan O., Basaran O., Gungor B., KAYIKÇIOĞLU L. M., ÖZKAN B., Kus M., et al.

ATHEROSCLEROSIS , 2024 (SCI-Expanded)

THE PREVALENCE AND IMPACT OF RENAL ARTERY STENOSIS IN PATIENTS UNDERGOING TAVI

ŞENER Y. Z., Yetkin A., ARDALI DÜZGÜN S., ATEŞ A. H., ŞAHİNER M. L., KAYA E. B., et al.

ATHEROSCLEROSIS , 2024 (SCI-Expanded)

EFFICACY AND SAFETY OF ALIROCUMAB IN PATIENTS WITH ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND WITHOUT ACUTE CORONARY SYNDROME OR STROKE: DATA MINING OF PHASE 3 ODYSSEY STUDIES

Filardi P. P., Tokgozoglu L., Cabezas M. C., Marx N., Tunon J., Pereira C., et al.

ATHEROSCLEROSIS , 2024 (SCI-Expanded)

ASSOCIATION BETWEEN ATHEROGENIC INDEX OF PLASMA AND BOTH CORONARY AND BREAST ARTERY CALCIFICATION

ŞENER Y. Z., Oksul M., Yildirim A., Sarikaya Y., Arslan S., ARDALI DÜZGÜN S., et al.

ATHEROSCLEROSIS , 2024 (SCI-Expanded)

Reply to Letter to the Editor: “Cardiotoxicity Associated with Antihuman Epidermal Growth Factor Receptor-2 Therapy: Particular Aspects of a Specific Phenomenon”

ŞENER Y. Z., Düzgün S. A., HAZIROLAN T., Tokgözoğlu L.

Anatolian Journal of Cardiology , cilt.28, sa.2, ss.130-131, 2024 (SCI-Expanded)

The year in cardiovascular medicine 2023: the top 10 papers in dyslipidaemias

Tokgozoglu L., Orringer C., Catapano A. L.

EUROPEAN HEART JOURNAL , sa.7, ss.504-506, 2024 (SCI-Expanded)

European Lipid Guidelines and Cardiovascular Risk Estimation: Current Status and Future Challenges

Pirillo A., Tokgözoğlu L., Catapano A. L.

Current Atherosclerosis Reports , 2024 (SCI-Expanded)

Current barriers and recommendations on the diagnosis of transthyretin amyloid cardiomyopathy: a Delphi study

ÇAVUŞOĞLU Y., BAŞARICI İ., Tüfekçioğlu O., ÖZPELİT E., ÖZDEMİR E., Sivrikoz İ. A., et al.

Frontiers in Cardiovascular Medicine , cilt.11, 2024 (SCI-Expanded)

World Heart Federation Roadmap for Secondary Prevention of Cardiovascular Disease: 2023 Update

Laranjo L., Lanas F., Sun M. C., Chen D. A., Hynes L., Imran T. F., et al.

Global heart , cilt.19, sa.1, ss.8, 2024 (SCI-Expanded)

Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid lowering

Norata G. D., Tokgozoglu L.

EUROPEAN HEART JOURNAL , sa.48, ss.5018-5020, 2023 (SCI-Expanded)

Influence of sex and gender on the biology of atherosclerotic cardiovascular disease: Special issue

Osto E., Roeters van Lennep J. E., Tokgözoğlu L., Öörni K.

Atherosclerosis , cilt.384, 2023 (SCI-Expanded)

Disconnect between triglyceride reduction and cardiovascular outcomes: lessons from the PROMINENT and CLEAR Outcomes trials

Tokgozoglu L., Pirillo A., Catapano A. L.

EUROPEAN HEART JOURNAL , sa.27, ss.2377-2379, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

Glycerol and β-hydroxybutyrate: friends or foes?

Tokgözoǧlu L., Pirillo A., Catapano A. L.

European Heart Journal , cilt.44, sa.39, ss.4183-4185, 2023 (SCI-Expanded)

Non-HDL-cholesterol in dyslipidemia: Review of the state-of-the-art literature and outlook

Raja V., Aguiar C., Alsayed N., Chibber Y. S., ElBadawi H., Ezhov M., et al.

Atherosclerosis , cilt.383, 2023 (SCI-Expanded)

Meta-analysis of the Current Research on the Relationship Between Blood Lipid Levels and the Occurrence of Atrial Fibrillation

Hayıroğlu M. İ., Şaylık F., Çınar T., Tokgözoğlu L.

Heart Lung and Circulation , cilt.32, sa.10, ss.1158-1166, 2023 (SCI-Expanded)

Role of Cardiovascular Imaging in Risk Assessment: Recent Advances, Gaps in Evidence, and Future Directions

Perone F., Bernardi M., Redheuil A., Mafrica D., Conte E., Spadafora L., et al.

Journal of Clinical Medicine , cilt.12, sa.17, 2023 (SCI-Expanded)

Pleiotropy of PCSK9: Functions in Extrahepatic Tissues

Şener Y. Z., Tokgözoğlu L.

Current Cardiology Reports , cilt.25, sa.9, ss.979-985, 2023 (SCI-Expanded)

Great debate: lipid-lowering therapies should be guided by vascular imaging rather than by circulating biomarkers

Tokgozoglu L., Morrow D. A., Nicholls S. J.

European heart journal , cilt.44, sa.25, ss.2292-2304, 2023 (SCI-Expanded)

Clinical characteristics of adult and paediatric patients with familial hypercholesterolemia: A real-life cross-sectional study from the Turkish National Database

Sonmez A., Demirci I., Haymana C., Tasci I., Ayvalı M. O., Ata N., et al.

Atherosclerosis , cilt.375, ss.9-20, 2023 (SCI-Expanded)

Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network

Catapano A. L., Tokgözoğlu L., Banach M., Gazzotti M., Olmastroni E., Casula M., et al.

Atherosclerosis , cilt.370, ss.5-11, 2023 (SCI-Expanded)

Underutilization of combination therapy in lipid lowering: a missed opportunity

Sener Y. Z., Tokgozoglu L.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , cilt.30, ss.367-369, 2023 (SCI-Expanded)

The year in cardiovascular medicine 2022: the top 10 papers in dyslipidaemias

Tokgozoglu L., Orringer C., Catapano A.

European heart journal , cilt.44, sa.4, ss.256-258, 2023 (SCI-Expanded)

Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach

ARMAĞAN B., OKŞUL M., ŞENER Y. Z., SARI A., ERDEN A., YARDIMCI G. K., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.2, ss.563-571, 2023 (SCI-Expanded)

Cardiac Magnetic Resonance Imaging Findings in Human Epidermal Growth Factor Receptor 2-Targeted Therapy-Related Cardiotoxicity

ŞENER Y. Z., Düzgün S. A., HAZIROLAN T., Tokgözoǧlu L.

Anatolian Journal of Cardiology , cilt.27, 2023 (SCI-Expanded)

Current Treatment Options in Homozygous Familial Hypercholesterolemia

Kayikcioglu M., Tokgozoglu L.

Pharmaceuticals , cilt.16, sa.1, 2023 (SCI-Expanded)

Paediatric familial hypercholesterolaemia screening in Europe: public policy background and recommendations

Gidding S. S., Wiegman A., Groselj U., Freiberger T., Peretti N., Dharmayat K., et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , cilt.29, ss.2301-2311, 2022 (SCI-Expanded)

PCSK9 Inhibition and Risk of Diabetes: Should We Worry?

Carugo S., Sirtori C. R., Corsini A., Tokgozoglu L., Ruscica M.

CURRENT ATHEROSCLEROSIS REPORTS , cilt.24, sa.12, ss.995-1004, 2022 (SCI-Expanded)

Comparison of Current International Guidelines for the Management of Dyslipidemia

AYGÜN S., Tokgozoglu L.

Journal of Clinical Medicine , cilt.11, sa.23, 2022 (SCI-Expanded)

A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms

Orringer C. E., Grant J. K., Tokgozoglu L.

CURRENT ATHEROSCLEROSIS REPORTS , cilt.24, sa.11, ss.839-847, 2022 (SCI-Expanded)

The spoils of war and the long-term spoiling of health conditions of entire nations

Navarese E. P., Grzelakowska K., Mangini F., Kubica J., Banach M., Benn M., et al.

ATHEROSCLEROSIS , cilt.352, ss.76-79, 2022 (SCI-Expanded)

Proceedings from the a:care congress: Adherence to medication: Time to recognise the elephant in the room

Tokgozoglu L., Weinman J.

ATHEROSCLEROSIS , cilt.350, ss.119-121, 2022 (SCI-Expanded)

Health related behaviours and physical activity level of hypertensive individuals during COVID-19 pandemic

Durukan B. N., VARDAR YAĞLI N., ÇALIK KÜTÜKCÜ E., Sener Y. Z., Tokgozoglu L.

INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH , cilt.45, sa.2, ss.176-183, 2022 (SCI-Expanded)

Current perceptions and practices in lipid management: results of a European Society of Cardiology/European Atherosclerosis Society Survey

Koskinas K. C., Catapano A. L., Baigent C., Tokgozoglu L., Mach F.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , cilt.28, sa.18, ss.2030-2037, 2022 (SCI-Expanded)

The year in cardiovascular medicine 2021: dyslipidaemia

Tokgozoglu L., Orringer C., Ginsberg H. N., Catapano A. L.

EUROPEAN HEART JOURNAL , cilt.43, sa.8, ss.807-818, 2022 (SCI-Expanded)

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

Visseren F. L. J., Mach F., Smulders Y. M., Carballo D., Koskinas K. C., Back M., et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , cilt.29, sa.1, ss.5-115, 2022 (SCI-Expanded)

The functional and structural evaluation of small fibers in asymptomatic carriers of TTR p.Val50Met (Val30Met) mutation

Bekircan-Kurt C. E., YILMAZ E., ARSLAN D., Yildiz F. G., DİKMETAŞ Ö., ERGÜL ÜLGER Z., et al.

NEUROMUSCULAR DISORDERS , cilt.32, sa.1, ss.50-56, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

<p>Prevention guidelines and EAS/ESC guidelines for the treatment of dyslipidaemias: A look to the future</p>

Catapano A. L., Ray K. K., Tokgozoglu L.

ATHEROSCLEROSIS , cilt.340, ss.51-52, 2022 (SCI-Expanded)

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Vallejo-Vaz A. J., Stevens C. A. T., Lyons A. R. M., Dharmayat K. I., Freiberger T., Hovingh G. K., et al.

LANCET , cilt.398, sa.10312, ss.1713-1725, 2021 (SCI-Expanded)

Familial Hypercholesterolemia: Global Burden and Approaches

Tokgozoglu L., KAYIKÇIOĞLU L. M.

CURRENT CARDIOLOGY REPORTS , cilt.23, sa.10, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

In-hospital statin initiation characteristics and one-year statin adherence rates in patients hospitalised for acute coronary syndrome

Simsek B., cinar T., Tanik V. O., Inan D., Avci I. I., Zeren G., et al.

ACTA CARDIOLOGICA , cilt.76, sa.8, ss.852-858, 2021 (SCI-Expanded)

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)

Visseren F. L. J., Mach F., Smulders Y. M., Carballo D., Koskinas K. C., Back M., et al.

EUROPEAN HEART JOURNAL , cilt.42, sa.34, ss.3227-3337, 2021 (SCI-Expanded)

The evaluation of small fibers in asymptomatic carriers of Val30Met mutation: Results of three years follow-up

Bekircan-Kurt C. E., YILMAZ E., Aslan D., Yildiz F. G., DİKMETAŞ Ö., ERGÜL ÜLGER Z., et al.

JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM , cilt.26, sa.3, ss.379, 2021 (SCI-Expanded)

Achieving post-percutaneous coronary intervention low-density lipoprotein-cholesterol goals: Science versus reality

Tokgozoglu L., Kocyigit D.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , cilt.28, sa.8, ss.852-853, 2021 (SCI-Expanded)

Medical Treatment in Coronary Patients: Is there Still a Gender Gap? Results from European Society of Cardiology EUROASPIRE V Registry

Vynckier P., Ferrannini G., Ryden L., Tokgozoglu L., Bruthans J., Kotseva K., et al.

CARDIOVASCULAR DRUGS AND THERAPY , cilt.35, sa.4, ss.801-808, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

The relationship between retinal microcirculation and right heart catheterization and echocardiography findings in patients with idiopathic pulmonary arterial hypertension

HEKİMSOY V., Kilinc Hekimsoy H., Sekeroglu M. A., KAYA E. B., Tokgozoglu L.

MICROCIRCULATION , cilt.28, sa.6, 2021 (SCI-Expanded)

Redefining cardiovascular risk prediction: is the crystal ball clearer now?

Tokgozoglu L., Torp-Pedersen C.

EUROPEAN HEART JOURNAL , cilt.42, sa.25, ss.2468-2471, 2021 (SCI-Expanded)

Taking action: European Atherosclerosis Society targets the United Nations Sustainable Development Goals 2030 agenda to fight atherosclerotic cardiovascular disease in Europe

Parini P., Frikke-Schmidt R., Tselepis A. D., Moulin P., von Eckardstein A., Binder C. J., et al.

ATHEROSCLEROSIS , cilt.322, ss.77-81, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

New cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?

Atar D., Jukema J. W., Molemans B., Taub P. R., Goto S., Mach F., et al.

ATHEROSCLEROSIS , cilt.319, ss.51-61, 2021 (SCI-Expanded)

An updated perspective and pooled analysis of cardiovascular outcome trials of GLP-1 receptor agonists and SGLT-2 inhibitors

Kilickap M., KAYIKÇIOĞLU L. M., Tokgozoglu L.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.25, sa.2, ss.61-80, 2021 (SCI-Expanded)

Should We Target Global Risk or Risk Factors?

Tokgozoglu L., Kocyigit D.

CURRENT ATHEROSCLEROSIS REPORTS , cilt.23, sa.1, 2021 (SCI-Expanded) Sürdürülebilir Kalkınma

How did the updated hemodynamic definitions affect the frequency of pulmonary hypertension in patients with systemic sclerosis?

SARI A., ŞENER Y. Z., ARMAĞAN B., KILIÇ L., KAYA E. B., HEKİMSOY V., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.25, sa.1, ss.30-35, 2021 (SCI-Expanded)

Transatlantic Lipid Guideline Divergence: Same Data But Different Interpretations

Orringer C. E., Tokgozoglu L., Maki K. C., Ray K. K., Saseen J. J., Catapano A. L.

JOURNAL OF THE AMERICAN HEART ASSOCIATION , cilt.9, sa.21, 2020 (SCI-Expanded)

Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel

Boren J., Chapman M. J., Krauss R. M., Packard C. J., Bentzon J. F., Binder C. J., et al.

EUROPEAN HEART JOURNAL , cilt.41, sa.24, ss.2313-2340, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

An Exploratory Analysis of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition and Aortic Stenosis in the FOURIER Trial

Bergmark B. A., O'Donoghue M. L., Murphy S. A., Kuder J. F., Ezhov M. V., Ceska R., et al.

JAMA CARDIOLOGY , cilt.5, sa.6, ss.709-713, 2020 (SCI-Expanded)

Mental status and physical activity in patients with homozygous familial hypercholesterolemia: A subgroup analysis of a nationwide survey (A-HIT1 registry)

KUMAN TUNÇEL Ö., Kayikcioglu M., PIRILDAR Ş., YILMAZ M., KAYNAR L., Aktan M., et al.

JOURNAL OF CLINICAL LIPIDOLOGY , cilt.14, sa.3, ss.361-372, 2020 (SCI-Expanded)

Role of femoral artery ultrasound imaging in cardiovascular event risk prediction in a primary prevention cohort at a medium-term follow-up

Kocyigit D., Gurses K. M., TAYDAŞ O., POKER A., ÖZER N., HAZIROLAN T., et al.

JOURNAL OF CARDIOLOGY , cilt.75, sa.5, ss.537-543, 2020 (SCI-Expanded)

Snapshot evaluation of acute and chronic heart failure in real-life in Turkey: A follow-up data for mortality

Yilmaz M. B., Aksakal E., Aksu U., Altay H., Nesligul Y., ÇELİK A., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.23, sa.3, ss.160-168, 2020 (SCI-Expanded)

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia: A Global Call to Action

Wilemon K. A., Patel J., Aguilar-Salinas C., Ahmed C. D., Alkhnifsawi M., Almahmeed W., et al.

JAMA CARDIOLOGY , cilt.5, sa.2, ss.217-229, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Anti-inflammatory therapy in atherosclerosis

Kocyigit D., Gurses K. M., Tokgozoglu L.

FRONTIERS IN BIOSCIENCE-LANDMARK , cilt.25, ss.242-269, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

Hegele R. A., Boren J., Ginsberg H. N., Arca M., Averna M., Binder C. J., et al.

LANCET DIABETES & ENDOCRINOLOGY , cilt.8, sa.1, ss.50-67, 2020 (SCI-Expanded)

An Update on the Role of PCSK9 in Atherosclerosis

Yurtseven E., Ural D., Baysal K., Tokgozoglu L.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS , cilt.27, sa.9, ss.909-918, 2020 (SCI-Expanded)

2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

Mach F., Baigent C., Catapano A. L., Koskinas K. C., Casula M., Badimon L., et al.

EUROPEAN HEART JOURNAL , cilt.41, sa.1, ss.111-188, 2020 (SCI-Expanded)

2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

Mach F., Baigent C., Catapano A. L., Koskina K. C., Casula M., Badimon L., et al.

ATHEROSCLEROSIS , cilt.290, ss.140-205, 2019 (SCI-Expanded)

PCSK9 inhibition and inflammation: A narrative review

Ruscica M., Tokgozoglu L., Corsini A., Sirtori C. R.

ATHEROSCLEROSIS , cilt.288, ss.146-155, 2019 (SCI-Expanded)

Percentage low-density lipoprotein-cholesterol response to a given statin dose is not fixed across the pre-treatment range: Real world evidence from clinical practice: Data from the ESC-EORP EUROASPIRE V Study

De Bacquer D., De Smedt D., Reiner Z., Tokgozoglu L., Clays E., Kotseva K., et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , 2019 (SCI-Expanded)

The association between serum angiogenin and osteopontin levels and coronary collateral circulation in patients with chronic total occlusion

Gurses K. M., YALÇIN M. U., Kocyigit D., Besler M. S., Caimmar H., Evranos B., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.22, sa.2, ss.77-84, 2019 (SCI-Expanded)

Atherosclerosis

Libby P., Buring J. E., Badimon L., Hansson C. K., Deanfield J., Bittencourt M. S., et al.

NATURE REVIEWS DISEASE PRIMERS , cilt.5, 2019 (SCI-Expanded)

Clinical management, psychosocial characteristics, and quality of life in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis in Turkey: Results of a nationwide survey (A-HIT1 registry)

Kayikcioglu M., Kuman-Tuncel O., Pirildar S., YILMAZ M., KAYNAR L., Aktan M., et al.

JOURNAL OF CLINICAL LIPIDOLOGY , cilt.13, sa.3, ss.455-467, 2019 (SCI-Expanded)

Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry

Kotseva K., De Backer G., De Bacquer D., Ryden L., Hoes A., Grobbee D., et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , cilt.26, sa.8, ss.824-835, 2019 (SCI-Expanded)

Incidence of cardiovascular events in patients with stabilized coronary heart disease: the EUROASPIRE IV follow-up study

De Bacquer D., De Smedt D., Kotseva K., Jennings C., Wood D., Ryden L., et al.

EUROPEAN JOURNAL OF EPIDEMIOLOGY , cilt.34, sa.3, ss.247-258, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk Insights From the FOURIER Trial

O'Donoghue M. L., Fazio S., Giugliano R. P., Stroes E. S. G., Kanevsky E., Gouni-Berthold I., et al.

CIRCULATION , cilt.139, sa.12, ss.1483-1492, 2019 (SCI-Expanded)

Are there any clinical and electrocardiographic predictors of heart rate reduction in relapsing- remitting multiple sclerosis patients treated with fingolimod?

Kocyigit D., YALÇIN M. U., Gurses K. M., Tokgozoglu L., KARABUDAK R.

MULTIPLE SCLEROSIS AND RELATED DISORDERS , cilt.27, ss.276-280, 2019 (SCI-Expanded)

Impact of Lipids on Cardiovascular Health JACC Health Promotion Series (Reprinted from J Am Coll Cardiol, vol 72, pg 1141-56, 2018)

Ference B. A., Graham I., Tokgozoglu L., Catapano A. L.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , cilt.72, sa.23, ss.2980-2995, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?

Kayikcioglu M., Tokgozoglu L., DOĞAN V., CEYHAN C., TUNÇEZ A., KUTLU M., et al.

ATHEROSCLEROSIS , cilt.277, ss.341-346, 2018 (SCI-Expanded)

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Vallejo-Vaz A. J., De Marco M., Stevens C. A. T., Akram A., Freiberger T., Hovingh G. K., et al.

ATHEROSCLEROSIS , cilt.277, ss.234-255, 2018 (SCI-Expanded)

Impact of Lipids on Cardiovascular Health JACC Health Promotion Series

Ference B. A., Graham I., Tokgozoglu L., Catapano A. L.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY , cilt.72, sa.10, ss.1141-1156, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

Pulmonary hypertension in Takayasu arteritis

SARI A., ŞENER Y. Z., Fira E., ARMAĞAN B., ERDEN A., OKŞUL M., et al.

INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES , cilt.21, sa.8, ss.1634-1639, 2018 (SCI-Expanded)

Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

Mach F., Ray K. K., Wiklund O., Corsini A., Catapano A. L., Bruckert E., et al.

EUROPEAN HEART JOURNAL , cilt.39, sa.27, ss.2526-2543, 2018 (SCI-Expanded)

Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directions

Kotsis V., Tsioufis K., Antza C., Seravalle G., Coca A., Sierra C., et al.

JOURNAL OF HYPERTENSION , cilt.36, sa.7, ss.1441-1455, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

New prospects for PCSK9 inhibition?

Landmesser U., Chapman M. J., Stock J. K., Amarenco P., Belch J. J. F., Boren J., et al.

EUROPEAN HEART JOURNAL , cilt.39, sa.27, ss.2600-2601, 2018 (SCI-Expanded)

Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment

Kotsis V., Jordan J., Micic D., Finer N., Leitner D. R., Toplak H., et al.

JOURNAL OF HYPERTENSION , cilt.36, sa.7, ss.1427-1440, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

A nation-wide survey of patients with homozygous familial hypercholesterolemia phenotype undergoing LDL-apheresis in Turkey (A-HIT 1 registry)

Kayikcioglu M., Tokgozoglu L., YILMAZ M., KAYNAR L., Aktan M., Durmus R. B., et al.

ATHEROSCLEROSIS , cilt.270, ss.42-48, 2018 (SCI-Expanded)

The challenge of risk prediction: How good are we?

Tokgozoglu L., Catapano A. L.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , cilt.25, sa.4, ss.418-419, 2018 (SCI-Expanded)

Low-Density Lipoprotein Cholesterol Lowering With Evolocumab and Outcomes in Patients With Peripheral Artery Disease: Insights From the FOURIER Trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)

Bonaca M. P., Nault P., Giugliano R. P., Keech A. C., Pineda A. L., Kanevsky E., et al.

CIRCULATION , cilt.137, sa.4, ss.338-350, 2018 (SCI-Expanded)

Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial

Giugliano R. P., Keech A., Murphy S. A., Huber K., TOKGÖZOĞLU S. L., Lewis B. S., et al.

JAMA CARDIOLOGY , cilt.2, sa.12, ss.1385-1391, 2017 (SCI-Expanded)

Preliminary results from a nationwide adult cardiology perspective for pulmonary hypertension: RegiStry on clInical outcoMe and sUrvival in pulmonaRy hypertension Groups (SIMURG)

Kaymaz C., MUTLU B., Kucukoglu M. S., Kaya B., AKDENİZ B., Avci B. K., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.18, sa.4, ss.242-250, 2017 (SCI-Expanded)

European Society of Cardiology/European Atherosclerosis Society Task Force consensus statement on proprotein convertase subtilisin/kexin type 9 inhibitors: practical guidance for use in patients at very high cardiovascular risk

Landmesser U., Chapman M. J., Farnier M., Gencer B., Gielen S., Hovingh G. K., et al.

EUROPEAN HEART JOURNAL , cilt.38, sa.29, ss.2245-2255, 2017 (SCI-Expanded)

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel

Ference B. A., Ginsberg H. N., Graham I., Ray K. K., Packard C. J., Bruckert E., et al.

EUROPEAN HEART JOURNAL , cilt.38, sa.32, ss.2459-2472, 2017 (SCI-Expanded)

Management of Blood Pressure and Heart Rate in Acute Decompensated Heart Failure with Volume Overload

KOÇYİĞİT D., Gurses K. M., YALÇIN M. U., Tokgozoglu L.

CURRENT PHARMACEUTICAL DESIGN , cilt.23, sa.31, ss.4609-4619, 2017 (SCI-Expanded)

Traditional and Alternative Therapies for Refractory Angina

KOÇYİĞİT D., Gurses K. M., Yalcin M. U., Tokgozoglu L.

CURRENT PHARMACEUTICAL DESIGN , cilt.23, sa.7, ss.1098-1111, 2017 (SCI-Expanded)

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS)

GÖRENEK B., Pelliccia A., Benjamin E. J., Boriani G., Crijns H. J., Fogel R. I., et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , cilt.24, sa.1, ss.4-40, 2017 (SCI-Expanded)

Anti-Hyperglycemic Agents for the Treatment of Type 2 Diabetes Mellitus: Role in Cardioprotection During the Last Decade

KOÇYİĞİT D., Gurses K. M., YALÇIN M. U., Tokgozoglu L.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS , cilt.17, sa.1, ss.19-31, 2017 (SCI-Expanded)

FREQUENCY OF CARDIOVASCULAR DISEASES AND DRUG USE IN TURKISH ELDERLY POPULATION FOLLOWED UP AT CARDIOLOGY CLINICS: THE ELDERTURK STUDY

ZOGHİ M., ÖZYÜNCÜ N., Ozal E., Cakmak H. A., Yayla C., Icli A., et al.

TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI , cilt.20, sa.2, ss.73-81, 2017 (SCI-Expanded)

Pre- and in-hospital antithrombotic management patterns and in-hospital outcomes in patients with acute coronary syndrome: data from the Turkish arm of the EPICOR study

Ertas F. S., Tokgozoglu L.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.16, sa.12, ss.900-915, 2016 (SCI-Expanded)

Prevalence of potential familial hypercholesteremia (FH) in 54,811 statin-treated patients in clinical practice

Catapano A. L., Lautsch D., Tokgozoglu L., Ferrieres J., Horack M., Farnier M., et al.

ATHEROSCLEROSIS , cilt.252, ss.1-8, 2016 (SCI-Expanded)

Cost of heart failure management in Turkey: results of a Delphi Panel

Aras D., Aydogdu S., Bozkurt E., ÇAVUŞOĞLU Y., Eren M., EROL Ç., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.16, sa.8, ss.554-562, 2016 (SCI-Expanded)

Prolonged Tp-e interval and Tp-e/QT correlates well with modified Rodnan skin severity score in patients with systemic sclerosis

Okutucu S., Karakulak U. N., Aksoy H., Sabanoglu C., HEKİMSOY V., Sahiner L., et al.

CARDIOLOGY JOURNAL , cilt.23, sa.3, ss.242-249, 2016 (SCI-Expanded)

Elevated Serum Beta-Trace Protein Levels are Associated With the Presence of Atrial Fibrillation in Hypertension Patients

Yalcin M. U., Gurses K. M., KOÇYİĞİT D., KESİKLİ S. A., Tokgozoglu L., GÜÇ D., et al.

JOURNAL OF CLINICAL HYPERTENSION , cilt.18, sa.5, ss.439-443, 2016 (SCI-Expanded)

The gender gap in risk factor control: Effects of age and education on the control of cardiovascular risk factors in male and female coronary patients. The EUROASPIRE IV study by the European Society of Cardiology

De Smedt D., De Bacquer D., De Sutter J., Dallongeville J., Gevaert S., De Backer G., et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY , cilt.209, ss.284-290, 2016 (SCI-Expanded)

Advanced heart failure and future of mechanical assist devices: a Consensus Report on Cardiology and Cardiovascular Surgery

YILMAZ M. B., AKAR A. R., Ekmekci A., Nalbantgil S., SADE AKDOĞAN L. E., Eren M., et al.

TURK GOGUS KALP DAMAR CERRAHISI DERGISI-TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY , cilt.24, sa.2, ss.201-212, 2016 (SCI-Expanded)

Current practice in identifying and treating cardiovascular risk, with a focus on residual risk associated with atherogenic dyslipidaemia

Ferrari R., Aguiar C., Alegria E., Bonadonna R. C., Cosentino F., Elisaf M., et al.

EUROPEAN HEART JOURNAL SUPPLEMENTS , cilt.18, 2016 (SCI-Expanded)

Role of Micronutrients on Subclinical Atherosclerosis

KOÇYİĞİT D., Gurses K. M., Yalcin M. U., Tokgozoglu L.

CURRENT PHARMACEUTICAL DESIGN , cilt.22, sa.2, ss.221-229, 2016 (SCI-Expanded) Sürdürülebilir Kalkınma

Enhanced Platelet Toll-like Receptor 2 and 4 Expression in Acute Coronary Syndrome and Stable Angina Pectoris

Gurses K. M., KOÇYİĞİT D., Yalcin M. U., CANPINAR H., OTO M. A., ÖZER N., et al.

AMERICAN JOURNAL OF CARDIOLOGY , cilt.116, sa.11, ss.1666-1671, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Patients with coronary artery disease and diabetes need improved management: a report from the EUROASPIRE IV survey: a registry from the EuroObservational Research Programme of the European Society of Cardiology

Gyberg V., De Bacquer D., De Backer G., Jennings C., Kotseva K., Mellbin L., et al.

CARDIOVASCULAR DIABETOLOGY , cilt.14, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

Practical approaches for the treatment of chronic heart failure: Frequently asked questions, overlooked points and controversial issues in current clinical practice

ÇAVUŞOĞLU Y., Altay H., Ekmekci A., Eren M., Kucukoglu M. S., NALBANTGİL S., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.15, ss.1-60, 2015 (SCI-Expanded)

A review of the evidence on reducing macrovascular risk in patients with atherogenic dyslipidaemia: A report from an expert consensus meeting on the role of fenofibrate-statin combination therapy

Aguiar C., Alegria E., Bonadonna R. C., Catapano A. L., Cosentino F., Elisaf M., et al.

ATHEROSCLEROSIS SUPPLEMENTS , cilt.19, 2015 (SCI-Expanded)

Periatrial epicardial adipose tissue thickness is an independent predictor of atrial fibrillation recurrence after cryoballoon-based pulmonary vein isolation

KOÇYİĞİT D., Gurses K. M., Yalcin M. U., TÜRK G., EVRANOS B., YORGUN H., et al.

JOURNAL OF CARDIOVASCULAR COMPUTED TOMOGRAPHY , cilt.9, sa.4, ss.295-302, 2015 (SCI-Expanded)

Trends in Gender Differences in Cardiac Care and Outcome After Acute Myocardial Infarction in Western Sweden: A Report From the Swedish Web System for Enhancement of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)

Redfors B., Angeras O., Ramunddal T., Petursson P., Haraldsson I., Dworeck C., et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION , cilt.4, sa.7, 2015 (SCI-Expanded)

Reflections from ACC 2015

Tokgozoglu L.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.15, sa.5, ss.347, 2015 (SCI-Expanded)

Functional exercise capacity, physical activity, and respiratory and peripheral muscle strength in pulmonary hypertension according to disease severity

SAĞLAM M., VARDAR YAĞLI N., ÇALIK KÜTÜKCÜ E., ARIKAN H., Savci S., İNAL İNCE D., et al.

JOURNAL OF PHYSICAL THERAPY SCIENCE , cilt.27, sa.5, ss.1309-1312, 2015 (SCI-Expanded)

Inspiratory Muscle Training in Pulmonary Arterial Hypertension

SAĞLAM M., ARIKAN H., VARDAR YAĞLI N., ÇALIK KÜTÜKCÜ E., İNAL İNCE D., SAVCI S., et al.

JOURNAL OF CARDIOPULMONARY REHABILITATION AND PREVENTION , cilt.35, sa.3, ss.198-206, 2015 (SCI-Expanded)

Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Stroes E. S., Thompson P. D., Corsini A., Vladutiu G. D., Raal F. J., Ray K. K., et al.

EUROPEAN HEART JOURNAL , cilt.36, sa.17, ss.1012-1024, 2015 (SCI-Expanded)

Effects of Persistent Atrial Fibrillation on Serum Galectin-3 Levels

GÜRSES K. M., YALÇIN M. U., KOÇYİĞİT D., CANPINAR H., EVRANOS B., YORGUN H., et al.

AMERICAN JOURNAL OF CARDIOLOGY , cilt.115, sa.5, ss.647-651, 2015 (SCI-Expanded)

Epicardial Fat Thickness is Increased in Vitamin D Deficient Premenopausal Women and does not Decrease after Short-term Replacement

GÜRSES K. M., Tokgozoglu L., YALÇIN M. U., KOÇYİĞİT D., EVRANOS B., YORGUN H., et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS , cilt.22, sa.6, ss.582-589, 2015 (SCI-Expanded)

Assessment of Cardiac Autonomic Nervous System Involvement in Systemic Sclerosis via Exercise Heart Rate Recovery

KARAKULAK U. N., OKUTUCU S., Sahiner L., Maharjan N., ALADAĞ KARAKULAK E., AKDOĞAN A., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.24, sa.1, ss.17-22, 2015 (SCI-Expanded)

Vitamin D and Epicardial Adipose Tissue - Reply -

GÜRSES K. M., Tokgozoglu L.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS , cilt.22, sa.7, ss.737, 2015 (SCI-Expanded)

Markers of subclinical atherosclerosis in premenopausal women with vitamin D deficiency and effect of vitamin D replacement

Gurses K. M., Tokgozoglu L., Yalcin M. U., Kocyigit D., Dural M., CANPINAR H., et al.

ATHEROSCLEROSIS , cilt.237, sa.2, ss.784-789, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Perspectives from The European Society of Cardiology Congress 2014

Tokgozoglu L.

ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.14, sa.7, ss.575, 2014 (SCI-Expanded)

The use of statins in people at risk of developing diabetes mellitus: Evidence and guidance for clinical practice

Sattar N. A., Ginsberg H., Ray K., Chapman M. J., Arca M., Averna M., et al.

ATHEROSCLEROSIS SUPPLEMENTS , cilt.15, sa.1, ss.1-15, 2014 (SCI-Expanded)

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia Executive summary

Grundy S. M., Arai H., Barter P., Bersot T. P., Betteridge D. J., Carmena R., et al.

ATHEROSCLEROSIS , cilt.232, sa.2, ss.410-413, 2014 (SCI-Expanded)

Plant sterols and plant stanols in the management of dyslipidaemia and prevention of cardiovascular disease

Gylling H., Plat J., Turley S., Ginsberg H. N., Ellegard L., Jessup W., et al.

ATHEROSCLEROSIS , cilt.232, sa.2, ss.346-360, 2014 (SCI-Expanded)

Residual macrovascular risk in 2013: what have we learned?

Fruchart J., Davignon J., Hermans M. P., Al-Rubeaan K., Amarenco P., Assmann G., et al.

CARDIOVASCULAR DIABETOLOGY , cilt.13, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

Pulmonary Hypertension in Systemic Lupus Erythematosus Pulmonary Thromboembolism Is the Leading Cause

AKDOĞAN A., KILIÇ L., Dogan I., OKUTUCU S., Er E., Kaya B., et al.

JCR-JOURNAL OF CLINICAL RHEUMATOLOGY , cilt.19, sa.8, ss.421-425, 2013 (SCI-Expanded)

An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia

Grundy S. M., Arai H., Barter P., Bersot T. P., Betteridge J., Carmena R., et al.

JOURNAL OF CLINICAL LIPIDOLOGY , cilt.7, sa.6, ss.561-565, 2013 (SCI-Expanded)

Stabilization of atherosclerotic plaques: an update

Yla-Herttuala S., Bentzon J. F., Daemen M., Falk E., Garcia-Garcia H. M., Herrmann J., et al.

EUROPEAN HEART JOURNAL , cilt.34, sa.42, ss.3251-3258, 2013 (SCI-Expanded)

Respiratory and peripheral muscle strength, and functional capacity in pulmonary hypertension patients with different functional classes

ARIKAN H., SAĞLAM M., VARDAR YAĞLI N., ÇALIK KÜTÜKCÜ E., İNAL İNCE D., Savci S., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.42, 2013 (SCI-Expanded)

Inspiratory muscle training in pulmonary hypertension

SAĞLAM M., ARIKAN H., VARDAR YAĞLI N., ÇALIK KÜTÜKCÜ E., İNAL İNCE D., Savci S., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.42, 2013 (SCI-Expanded)

The Clinical and Hemodynamic Characteristics of Transition to Eisenmenger Syndrome in Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: A National Multicenter Study

Kaymaz C., Kucukoglu S., Saylam G. S., KULA S., ALEHAN D., Tokgozoglu L., et al.

CIRCULATION , cilt.126, sa.21, 2012 (SCI-Expanded)

A Comparison of Clinical and Hemodynamic Characteristics of Pre- and Post-Tricuspid Congenital Shunts Resulting in Pulmonary Arterial Hypertension: Insights from a National Study

Kaymaz C., Kucukoglu S., Saylam G. S., ALEHAN D., Tokgozoglu L., KULA S., et al.

CIRCULATION , cilt.126, sa.21, 2012 (SCI-Expanded)

A Significant Difference Between Survival Estimates Predicted by National Institutes of Health and Pulmonary Hypertension Connection Models Based on Same Hemodynamic Measures in Patients with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

Kaymaz C., Kucukoglu S., Saylam G. S., ALEHAN D., Tokgozoglu L., KULA S., et al.

CIRCULATION , cilt.126, sa.21, 2012 (SCI-Expanded)

Peripheral and respiratory muscle strength in pulmonary artery hypertension

SAĞLAM M., VARDAR YAĞLI N., ÇALIK KÜTÜKCÜ E., ARIKAN H., Savci S., İNAL İNCE D., et al.

EUROPEAN RESPIRATORY JOURNAL , cilt.40, 2012 (SCI-Expanded)

Implementation, target population, compliance and barriers to risk guided therapy

Tokgozoglu L., Bruckert E.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY , cilt.19, ss.37-41, 2012 (SCI-Expanded) Sürdürülebilir Kalkınma

Assessment of the relationship between non-dipping phenomenon and heart rate turbulence

Sahiner L., OKUTUCU S., KARAKULAK U. N., AYTEMİR K., Fatihoglu S. G., KAYA E. B., et al.

CARDIOLOGY JOURNAL , cilt.19, sa.2, ss.140-145, 2012 (SCI-Expanded)

Antihypertensive Drugs and Inflammation in Acute Ischemic Stroke as a Predictor Factor of Future Cardiovascular Mortality

Benbir G., Ince B., Kumral E., Ongen Z., Kultursay H., Tokgozoglu L., et al.

INFLAMMATION , cilt.35, sa.1, ss.65-73, 2012 (SCI-Expanded)

The relationship between circadian blood pressure pattern and ventricular repolarization dynamics assessed by QT dynamicity

OKUTUCU S., KARAKULAK U. N., Sahiner L., AYTEMİR K., Demiri E., EVRANOS B., et al.

BLOOD PRESSURE MONITORING , cilt.17, sa.1, ss.14-19, 2012 (SCI-Expanded)

Involvement of Autonomic Nervous System and its Relationship With Cranial and Cervical Spinal MRI Findings In Patients With Multiple Sclerosis

Ciftci O., KESER İ., Kurne A., Bosnak Guclu M., Karli Oguz K., Soylu R., et al.

JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH , cilt.29, sa.2, ss.181-191, 2012 (SCI-Expanded)

Relationship of PON2 gene Ser311Cys polymorphism and serum paraoxonase activity with coronary artery disease in Turkish population

Bayrak T., Bayrak A., VOLKAN SALANCI B., Deniz A., TOKGÖZOĞLU S. L., YAVUZ B., et al.

TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI , cilt.37, sa.2, ss.150-155, 2012 (SCI-Expanded)

Serum PON-1 Activity but not Q192R Polymorphism is Related to the Extent of Atherosclerosis

Bayrak A., Bayrak T., TOKGÖZOĞLU S. L., VOLKAN SALANCI B., Deniz A., YAVUZ B., et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS , cilt.19, sa.4, ss.376-384, 2012 (SCI-Expanded)

Exercise Capacity, Peripheral Muscle Strength, and Inactivity in Diabetic Patients With Heart Failure

Bosnak-Guclu M., Savci S., İNAL İNCE D., ARIKAN H., Tulumen E., AYTEMİR K., et al.

TOPICS IN GERIATRIC REHABILITATION , cilt.28, sa.1, ss.54-59, 2012 (SSCI) Sürdürülebilir Kalkınma

Baseline aortic pre-ejection interval predicts reverse remodeling and clinical improvement after cardiac resynchronization therapy

Aksoy H., OKUTUCU S., AYTEMİR K., KAYA E. B., EVRANOS B., Kabakci G., et al.

CARDIOLOGY JOURNAL , cilt.18, sa.6, ss.639-647, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

Effects of inspiratory muscle training in patients with heart failure

Bosnak-Guclu M., ARIKAN H., Savci S., İNAL İNCE D., Tulumen E., AYTEMİR K., et al.

RESPIRATORY MEDICINE , cilt.105, sa.11, ss.1671-1681, 2011 (SCI-Expanded)

The Reproducibility of Heart Rate Recovery after Treadmill Exercise Test

Tulumen E., Khalilayeva I., AYTEMİR K., KAYA E. B., DEVECİ O. S., Aksoy H., et al.

ANNALS OF NONINVASIVE ELECTROCARDIOLOGY , cilt.16, sa.4, ss.365-372, 2011 (SCI-Expanded)

Cardiologists' educational needs for preventive cardiology in Europe

Tokgozoglu L., Vidal P. M., Vanuzzo D.

EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION , cilt.18, sa.5, ss.743-744, 2011 (SCI-Expanded)

Serum Antioxidant Vitamin Levels in Patients with Coronary Heart Disease

YILDIRAN H., Mercanligil S. M., BESLER H. T., Tokgozoglu L., KEPEZ A.

INTERNATIONAL JOURNAL FOR VITAMIN AND NUTRITION RESEARCH , cilt.81, sa.4, ss.211-217, 2011 (SCI-Expanded)

Stabilisation of atherosclerotic plaques Position Paper of the European Society of Cardiology (ESC) Working Group on Atherosclerosis and Vascular Biology

Yla-Herttuala S., Bentzon J. F., Daemen M., Falk E., Garcia-Garcia H. M., Herrmann J., et al.

THROMBOSIS AND HAEMOSTASIS , cilt.106, sa.1, ss.1-19, 2011 (SCI-Expanded)

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

Chapman M. J., Ginsberg H. N., Amarenco P., Andreotti F., Boren J., Catapano A. L., et al.

EUROPEAN HEART JOURNAL , cilt.32, sa.11, ss.1345-1361, 2011 (SCI-Expanded)

Cardiac resynchronization therapy improves exercise heart rate recovery in patients with heart failure

OKUTUCU S., AYTEMİR K., EVRANOS B., Aksoy H., Sabanov C., KARAKULAK U. N., et al.

EUROPACE , cilt.13, sa.4, ss.526-532, 2011 (SCI-Expanded)

Relationship between atrial septal aneurysms and atrial electromechanical delay

OKUTUCU S., EVRANOS B., AYTEMİR K., KAYA E. B., DEVECİ O. S., Deniz A., et al.

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING , cilt.27, sa.4, ss.505-513, 2011 (SCI-Expanded)

A comparison of pulmonary function, peripheral and respiratory muscle strength and functional capacity in the heart failure patients with different functional classes

GÜÇLÜ M. B., İNAL İNCE D., ARIKAN H., Savci S., Tulumen E., Tokgozoglu L.

ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.11, sa.2, ss.101-106, 2011 (SCI-Expanded)

Improvement in Right Ventricular Systolic Function after Cardiac Resynchronization Therapy Correlates with Left Ventricular Reverse Remodeling

Aksoy H., OKUTUCU S., AYTEMİR K., KAYA E. B., Tulumen E., EVRANOS B., et al.

PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY , cilt.34, sa.2, ss.200-207, 2011 (SCI-Expanded)

The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in Turkey

YAZICI M. S., YAGCIOGLU A. E., ERTUĞRUL A., ENI N., KARAHAN S., KARAAGAOGLU E., et al.

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE , cilt.261, sa.1, ss.69-78, 2011 (SCI-Expanded)

Evaluation of cardiac autonomic functions in patients with ankylosing spondylitis via heart rate recovery and heart rate variability

KAYA E. B., OKUTUCU S., Aksoy H., KARAKULAK U. N., Tulumen E., ÖZDEMİR O., et al.

CLINICAL RESEARCH IN CARDIOLOGY , cilt.99, sa.12, ss.803-808, 2010 (SCI-Expanded)

Lipoprotein(a) as a cardiovascular risk factor: current status

Nordestgaard B. G., Chapman M. J., Ray K., Boren J., Andreotti F., Watts G. F., et al.

EUROPEAN HEART JOURNAL , cilt.31, sa.23, ss.2844-2855, 2010 (SCI-Expanded)

Basal Left Ventricular Diastolic Functions Predicts Super-response To Cardiac Resynchronization Therapy

OKUTUCU S., Aksoy H., AYTEMİR K., EVRANOS B., Kaya E. B., Kabakci G., et al.

CIRCULATION , cilt.122, sa.21, 2010 (SCI-Expanded)

Therapeutic algorithms in pulmonary hypertension in the light of current guidelines

OKUTUCU S., Tokgozoglu L.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.10, ss.19-26, 2010 (SCI-Expanded)

Evaluation of the Impact of Treatment on Endothelial Function and Cardiac Performance in Acromegaly

Akgul E., Tokgozoglu L., Erbas T., Kabakci G., AYTEMİR K., Haznedaroglu I., et al.

ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES , cilt.27, sa.8, ss.990-996, 2010 (SCI-Expanded)

Autologous Transplantation of Arterial Cells Improves Cardiac Function in a Rabbit Model of Infarcted Myocardium

Tokac M., Aktan M., AK A., Duman S., Tokgozoglu L., AYGÜL N., et al.

STEM CELLS AND DEVELOPMENT , cilt.19, sa.6, ss.927-934, 2010 (SCI-Expanded)